46 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
7 May 24
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
4:02pm
and completion of clinical trials; disruption to our operations from the COVID-19 pandemic, including clinical trial delays; the Company’s dependence on third
8-K
EX-99.1
GOSS
Gossamer Bio Inc
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
in the commencement, enrollment and completion of clinical trials; disruption to our operations from the COVID-19 pandemic, including clinical trial
8-K
EX-99.1
c187hxvy2
8 Aug 23
Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update
4:01pm
8-K
EX-99.1
gvmyc6gf7pz
9 May 23
Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update
4:03pm
8-K
m8p5a
6 Dec 22
Other Events
7:36am
8-K
EX-99.1
en84 at47edcxnkb63u
3 Nov 22
Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update
4:00pm
8-K
EX-99.1
lom7q4piqqfyeph qqh
9 Aug 22
Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update
8:08am
8-K
EX-99.1
sdurw1xt24l3yfz2c
10 May 22
Gossamer Bio Announces First Quarter 2022 Financial Results and Provides Business Update
4:04pm
8-K
htt6j0b7
25 Apr 22
Results of Operations and Financial Condition
8:14am
8-K
EX-99.1
8mlsdwa brw914v3
3 Mar 22
Gossamer Bio Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Business Update
4:02pm